Corrigendum to "Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice".

Published in: Mediators of inflammation (2016)

[This corrects the article DOI: 10.1155/2016/1405924.].

Keyphrases